Financials

  • Market Capitalization 1.51 B
  • Employee 159
  • Founded 1996
  • CEO N/A
  • Website www.inva.com
  • Headquarter Delaware, United States
  • FIGI BBG000CG9XT7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
5.22
Rapporto prezzo/fatturato
4.2

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2175
LBRX
LB Pharmaceuticals Inc - Common Stock
47.73 USD-0.33%-0.31%+18.17%+151.21%1.54 B USD
2179
NVAX
Novavax, Inc. - Common Stock
9.26 USD+2.32%+4.28%+24.46%+25.30%1.53 B USD
2192
ABSI
Absci Corporation - Common Stock
8.71 USD-7.54%-6.65%+11.52%+270.64%1.49 B USD
2195
TYRA
Tyra Biosciences, Inc. - Common Stock
24.94 USD-4.55%-4.04%-24.56%+73.92%1.49 B USD

Notizie